<DOC>
	<DOCNO>NCT00724698</DOCNO>
	<brief_summary>Eligible patient prescribe Desloratadine 1 tablet 5 mg daily . Patients ask follow-up final visit 14 day ( Day 15 ) safety , tolerability clinical efficacy measure .</brief_summary>
	<brief_title>Evaluation Desloratadine When Used Patients With Either Allergic Rhinitis Chronic Idiopathic Urticaria</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<criteria>Outpatient men woman , age 12 year . Diagnosis Allergic Rhinitis Chronic Idiopathic Urticaria Known hypersensitivity Desloratadine . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>